minocycline and Trypanosomiasis

minocycline has been researched along with Trypanosomiasis* in 1 studies

Other Studies

1 other study(ies) available for minocycline and Trypanosomiasis

ArticleYear
CD200 receptors are differentially expressed and modulated by minocycline in the brain during Trypanosoma brucei infection.
    Journal of neuroimmunology, 2010, Sep-14, Volume: 226, Issue:1-2

    Infection with Trypanosoma brucei, which causes African trypanosomiasis, activates microglia, which are constitutively maintained in a quiescent state through CD200-CD200 receptor interactions. C57BL/6 mice have one inhibitory receptor, CD200R and three activating members, CD200 receptor-like (RL)a-c. Infection increased MAC-1 (microglia marker), CD200RLa and CD200RLb, but not CD200, CD200R or CD200RLc, transcript levels in the brains. Minocycline treatment inhibited the infection-induced elevation of MAC-1 and CD200RLa transcripts, but had no significant effect on CD200 or the other receptors. This suggests that CD200RLa might play a role in microglia/macrophage activation during trypanosome infection.

    Topics: Animals; Anti-Bacterial Agents; Antigens, CD; Brain; Gene Expression Regulation; Macrophage-1 Antigen; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Minocycline; RNA, Messenger; Spleen; Statistics, Nonparametric; Time Factors; Trypanosoma brucei brucei; Trypanosomiasis

2010